552 related articles for article (PubMed ID: 21939428)
1. Venoms as a platform for human drugs: translating toxins into therapeutics.
King GF
Expert Opin Biol Ther; 2011 Nov; 11(11):1469-84. PubMed ID: 21939428
[TBL] [Abstract][Full Text] [Related]
2. Advances in venom peptide drug discovery: where are we at and where are we heading?
Smallwood TB; Clark RJ
Expert Opin Drug Discov; 2021 Oct; 16(10):1163-1173. PubMed ID: 33914674
[No Abstract] [Full Text] [Related]
3. Venom peptides as therapeutics: advances, challenges and the future of venom-peptide discovery.
Robinson SD; Undheim EAB; Ueberheide B; King GF
Expert Rev Proteomics; 2017 Oct; 14(10):931-939. PubMed ID: 28879805
[TBL] [Abstract][Full Text] [Related]
4. Peptide therapeutics from venom: Current status and potential.
Pennington MW; Czerwinski A; Norton RS
Bioorg Med Chem; 2018 Jun; 26(10):2738-2758. PubMed ID: 28988749
[TBL] [Abstract][Full Text] [Related]
5. Animal toxins - Nature's evolutionary-refined toolkit for basic research and drug discovery.
Herzig V; Cristofori-Armstrong B; Israel MR; Nixon SA; Vetter I; King GF
Biochem Pharmacol; 2020 Nov; 181():114096. PubMed ID: 32535105
[TBL] [Abstract][Full Text] [Related]
6. Spider venomics: implications for drug discovery.
Pineda SS; Undheim EA; Rupasinghe DB; Ikonomopoulou MP; King GF
Future Med Chem; 2014 Oct; 6(15):1699-714. PubMed ID: 25406008
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological screening technologies for venom peptide discovery.
Prashanth JR; Hasaballah N; Vetter I
Neuropharmacology; 2017 Dec; 127():4-19. PubMed ID: 28377116
[TBL] [Abstract][Full Text] [Related]
8. Venom peptides as pharmacological tools and therapeutics for diabetes.
Robinson SD; Safavi-Hemami H
Neuropharmacology; 2017 Dec; 127():79-86. PubMed ID: 28689026
[TBL] [Abstract][Full Text] [Related]
9. Molecular Simulations of Disulfide-Rich Venom Peptides with Ion Channels and Membranes.
Deplazes E
Molecules; 2017 Feb; 22(3):. PubMed ID: 28264446
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of venom peptides.
Lewis RJ; Garcia ML
Nat Rev Drug Discov; 2003 Oct; 2(10):790-802. PubMed ID: 14526382
[TBL] [Abstract][Full Text] [Related]
11. Diversity of peptide toxins from stinging ant venoms.
Aili SR; Touchard A; Escoubas P; Padula MP; Orivel J; Dejean A; Nicholson GM
Toxicon; 2014 Dec; 92():166-78. PubMed ID: 25448389
[TBL] [Abstract][Full Text] [Related]
12. The future of peptide-based drugs.
Craik DJ; Fairlie DP; Liras S; Price D
Chem Biol Drug Des; 2013 Jan; 81(1):136-47. PubMed ID: 23253135
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular-Active Venom Toxins: An Overview.
Rebello Horta CC; Chatzaki M; Rezende BA; Magalhães Bde F; Duarte CG; Felicori LF; Ribeiro Oliveira-Mendes BB; do Carmo AO; Chávez-Olórtegui C; Kalapothakis E
Curr Med Chem; 2016; 23(6):603-22. PubMed ID: 26812904
[TBL] [Abstract][Full Text] [Related]
14. Molecular dissection of venom from Chinese scorpion Mesobuthus martensii: identification and characterization of four novel disulfide-bridged venom peptides.
Zeng XC; Luo F; Li WX
Peptides; 2006 Jul; 27(7):1745-54. PubMed ID: 16513212
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles Functionalized with Venom-Derived Peptides and Toxins for Pharmaceutical Applications.
Dos Santos AP; de Araújo TG; Rádis-Baptista G
Curr Pharm Biotechnol; 2020; 21(2):97-109. PubMed ID: 31223083
[TBL] [Abstract][Full Text] [Related]
16. High-throughput expression of animal venom toxins in Escherichia coli to generate a large library of oxidized disulphide-reticulated peptides for drug discovery.
Turchetto J; Sequeira AF; Ramond L; Peysson F; Brás JL; Saez NJ; Duhoo Y; Blémont M; Guerreiro CI; Quinton L; De Pauw E; Gilles N; Darbon H; Fontes CM; Vincentelli R
Microb Cell Fact; 2017 Jan; 16(1):6. PubMed ID: 28095880
[TBL] [Abstract][Full Text] [Related]
17. Centipede venoms as a source of drug leads.
Undheim EA; Jenner RA; King GF
Expert Opin Drug Discov; 2016 Dec; 11(12):1139-1149. PubMed ID: 27611363
[TBL] [Abstract][Full Text] [Related]
18. Selective targeting of G-protein-coupled receptor subtypes with venom peptides.
Näreoja K; Näsman J
Acta Physiol (Oxf); 2012 Feb; 204(2):186-201. PubMed ID: 21481193
[TBL] [Abstract][Full Text] [Related]
19. VenomFlow: An Automated Bioinformatic Pipeline for Identification of Disulfide-Rich Peptides from Venom Arsenals.
Achrak E; Ferd J; Schulman J; Dang T; Krampis K; Holford M
Methods Mol Biol; 2022; 2498():89-97. PubMed ID: 35727542
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology and therapeutic potential of venom peptides.
Robinson SD; Vetter I
Biochem Pharmacol; 2020 Nov; 181():114207. PubMed ID: 32857993
[No Abstract] [Full Text] [Related]
[Next] [New Search]
